IL6 and Alzheimer disease: Furthermore, the protein levels of IL-6, IL-1β, and TNF-α were higher in the hippocampus of LPS- or Aβ1−42-induced AD model mice, and MMI-0100 treatment markedly down-regulated the expression of IL-6, IL-1β, and TNF-α (Figure 6).